Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CELA3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RGPD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPRC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LGR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INHBA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKIL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLU7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GCLC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGLEC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RPS27L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LACC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHTOP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL36G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED13L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on